Abiopharma

New Form SCHEDULE 13G/A - ADDENTAX GROUP CORP. <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001493152-26-039391 <b>Size:</b> 6 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001918704-26-024317 <b>Size:</b> 520 KB

General Announcement: Share Buy-Back

Midroog announcement on rating regarding a possible public offering of securities, through First International Issues Ltd. (subsidiary)

New Form N-PX - INVESCO QQQ TRUST, SERIES 1 <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001193125-26-358231 <b>Size:</b> 897 KB

New Form SCHEDULE 13D/A - ADDENTAX GROUP CORP. <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001493152-26-039388 <b>Size:</b> 5 KB

New Form N-PX - Nuveen S&P 500 Dynamic Overwrite Fund <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0000930413-26-002619 <b>Size:</b> 3 MB

New Form SCHEDULE 13G - ADDENTAX GROUP CORP. <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001493152-26-039385 <b>Size:</b> 7 KB

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of interest/ Changes in interest of Directors/ Chief Executive Officer

New Form N-PX - NUVEEN REAL ESTATE INCOME FUND <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0000930413-26-002617 <b>Size:</b> 245 KB

New Form SCHEDULE 13G - ADDENTAX GROUP CORP. <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001493152-26-039382 <b>Size:</b> 6 KB

New Form N-PX - Nuveen Real Asset Income & Growth Fund <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0000930413-26-002616 <b>Size:</b> 1 MB

Change in holdings of interested parties/officers

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Changes in Interest of Substantial Shareholders

Waiver: Waivers from compliance with certain rules of the SGXT-ST Listing Manual